Non-small cell lung cancer

In Non-small cell lung cancer Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Gefimipsa 250mg Capsule helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

Take this medicine in the dose and duration as advised by your doctor. Gefimipsa 250mg Capsule may be taken with or without food but it is better to take it at a fixed time.

Gefimipsa 250mg Capsule is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body who have abnormal epidermal growth factor receptor (EGFR) genes and who have not had previous treatment for cancer.Gefimipsa 250mg Capsule should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Your doctor may advice for regular monitoring of liver function while your taking this medicine.Common side effects include diarrhea dry skin loss of appetite and nausea. Drink plenty of fluids to reduce the risk of side effects. Inform your doctor if any of the side effects bother you or get worse. In case you develop ulceration in mouth changes in your vision or breathing difficulties than it is better to inform the doctor.Women who are undergoing treatment should use effective contraception method. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine. Let your doctor also know about all the other medications you are taking.

Take this medicine in the dose and duration as advised by your doctor. Gefimipsa 250mg Capsule may be taken with or without food but it is better to take it at a fixed time.

- Alcohol : UNSAFE <p> It is unsafe to consume alcohol with Gefimipsa 250mg Capsule. | - Pregnancy : CONSULT YOUR DOCTOR <p> Gefimipsa 250mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR <p> Gefimipsa 250mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. | - Driving : UNSAFE <p> Gefimipsa 250mg Capsule may cause side effects which could affect your ability to drive. | - Kidney : CAUTION <p> Gefimipsa 250mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Gefimipsa 250mg Capsule may be needed. Please consult your doctor. | - Liver : SAFE IF PRESCRIBED <p> Gefimipsa 250mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefimipsa 250mg Capsule may not be needed in these patients. Please consult your doctor.

If you miss a dose of Gefimipsa 250mg Capsule skip it and continue with your normal schedule. Do not double the dose.

Chemical Class :: Quinazolinamines|Habit Forming :: No|Therapeutic Class :: ANTI NEOPLASTICS

Non-small cell lung cancer

Diarrhea | Dry skin | Loss of appetite | Nausea | Rash | Vomiting | Weakness | Weight loss | Eating disorder | Allergic reaction